Insider · CIK 0001540354
David A Rosa
Files at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp), BRTX (BioRestorative Therapies, Inc.). First filing Apr 7, 2025, latest Apr 7, 2025.
David A Rosa files SEC Form 4 as CEO, president and director at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp), and also at BRTX (BioRestorative Therapies, Inc.). Since Apr 7, 2025, David A Rosa has reported 1 open-market buy worth $50k and 0 open-market sells worth $0, the latest filed on Apr 7, 2025.
A track record needs three past buys with six months of prices behind them; David A Rosa has 0, so none is measured yet.
The newest scored trade: bought $50k of NMTC on Apr 4, 2025, filed Apr 7, 2025, scored 61 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NMTC: NEUROONE MEDICAL TECHNOLOGIES Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | NEUROONE MEDICAL TECHNOLOGIES Corp | $50k 100,000 shares | +9% | 0% from low-61% from high |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | FTax withholding Common Stock | -2,458 | $0.78 | $1,910 | 1,080,132 | Apr 1, 2026 |
| Feb 18, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | FTax withholding Common Stock | -71,325 | $0.68 | $49k | 1,082,590 | Feb 20, 2026 |
| Dec 31, 2025 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | FTax withholding Common Stock | +2,458 | $0.76 | $1,863 | 1,153,915 | Jan 5, 2026 |
| Sep 30, 2025 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | FTax withholding Common Stock | -2,458 | $0.89 | $2,184 | 1,156,373 | Oct 1, 2025 |
| Jun 30, 2025 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | FTax withholding Common Stock | -2,458 | $0.68 | $1,667 | 1,158,831 | Jul 2, 2025 |
| Apr 17, 2025 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | AGrant or award Option to Purchase Common Stockderivative | +750,000 | $0.00 | $0 | 750,000 | Apr 21, 2025 |
| Apr 4, 2025 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | POpen-market purchase Common Stock | +100,000 | $0.50 | $50k | 1,161,289 | Apr 7, 2025 |
| Mar 31, 2025 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | FTax withholding Common Stock | -2,458 | $0.85 | $2,090 | 1,061,289 | Apr 2, 2025 |
| Feb 14, 2025 | BRTX BioRestorative Therapies, Inc. | AGrant or award Stock Optionderivative | +52,632 | $0.00 | $0 | 52,632 | Feb 19, 2025 |
| Nov 30, 2024 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | FTax withholding Common Stock | -2,239 | $0.62 | $1,395 | 1,142,008 | Dec 3, 2024 |
| Oct 31, 2024 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | FTax withholding Common Stock | -2,239 | $0.97 | $2,172 | 1,144,247 | Nov 1, 2024 |
Questions about David A Rosa
Answered from the filings on this page, as of the latest one.
Is David A Rosa buying or selling?
Not in the last 12 months. David A Rosa's latest open-market trade on SEC Form 4 was bought $50k of NMTC on Apr 4, 2025.
How did David A Rosa's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David A Rosa has 0.
Where does David A Rosa file Form 4?
David A Rosa has filed Form 4 at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp) as CEO and President; BRTX (BioRestorative Therapies, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.